Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oncopeptides AB | 48,752 | net | 24 Feb 2022 | tx 16+116,800−68,048 |
| Sprint Bioscience AB | 40,000 | net | 21 Nov 2023 | tx 2+40,000 |
| Oncopeptides AB | -2,000 | net | 13 Jul 2018 | tx 2−2,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Nov 2023 | PURCHASE | Sprint Bioscience AB | 20,000 | 2.10 SEK | first after silence |
| 24 Feb 2022 | PURCHASE | Oncopeptides AB | 11,700 | 0.11 SEK | anomaly |
| 24 Nov 2021 | PURCHASE | Oncopeptides AB | 5,000 | 11.51 SEK | |
| 14 Sept 2021 | PURCHASE | Oncopeptides AB | 1,000 | 42.76 SEK | |
| 28 May 2021 | PURCHASE | Oncopeptides AB | 2,000 | 100.00 SEK | first after silence |
| 15 Jan 2021 | SALE | Oncopeptides AB | 4,652 | 166.00 SEK | |
| 14 Nov 2019 | PURCHASE | Oncopeptides AB | 2,000 | 11.85 SEK | |
| 14 Oct 2019 | PURCHASE | Oncopeptides AB | 2,000 | 113.10 SEK | |
| 24 Sept 2019 | GRANT_AWARD | Oncopeptides AB | 33,000 | 0.11 SEK | deriv |
| 24 Sept 2019 | SALE | Oncopeptides AB | 18,648 | 124.80 SEK | |
| 25 Sept 2018 | SALE | Oncopeptides AB | 15,000 | 161.40 SEK | |
| 02 Aug 2018 | PURCHASE | Oncopeptides AB | 26,100 | 1.00 SEK | first after silence |
| 02 Aug 2018 | SALE | Oncopeptides AB | 5,000 | 154.80 SEK | |
| 02 Aug 2018 | SALE | Oncopeptides AB | 6,100 | 154.60 SEK | |
| 13 Jul 2018 | SALE | Oncopeptides AB | 1,000 | 199.80 SEK | |
| 14 Jul 2017 | PURCHASE | Oncopeptides AB | 1,000 | 63.68 SEK |
3 purchases reported after at least 12 months of silence — most recent on 21 Nov 2023.